Van den Steen, Philippe E. and Van Aelst, Ilse and Hvidberg, Vibeke and Piccard, Helene and Fiten, Pierre and Jacobsen, Christian and Moestrup, Soren K. and Fry, Simon and Royle, Louise and Wormald, Mark R. and Wallis, Russell and Rudd , Pauline M. and Dwek, Raymond A. and Opdenakker, Ghislain (2006) The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors. Journal of Biological Chemistry, 281 (27). pp. 18626-18637. ISSN 0021-9258
Full text not available from this repository.
Gelatinase B/matrix metalloproteinase-9 (MMP-9), a key regulator and effector of immunity, contains a C-terminal hemopexin domain preceded by a unique linker sequence of ∼64 amino acid residues. This linker sequence is demonstrated to be an extensively O-glycosylated (OG) domain with a compact three-dimensional structure. The OG and hemopexin domains have no influence on the cleavage efficiency of MMP-9 substrates. In contrast, the hemopexin domain contains a binding site for the cargo receptor low density lipoprotein receptor-related protein-1 (LRP-1). Furthermore, megalin/LRP-2 is identified as a new functional receptor for the hemopexin domain of MMP-9, able to mediate the endocytosis and catabolism of the enzyme. The OG domain is required to correctly orient the hemopexin domain for inhibition by TIMP-1 and internalization by LRP-1 and megalin. Therefore, the OG and hemopexin domains down-regulate the bioavailability of active MMP-9 and the interactions with the cargo receptors are proposed to be the original function of hemopexin domains in MMPs.
|Research Community:||University of Westminster > Life Sciences, School of|
|Deposited On:||13 Mar 2012 14:51|
|Last Modified:||13 Mar 2012 14:51|
Repository Staff Only: item control page